Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:CHR NYSE:FC NASDAQ:NEO NYSE:PAY On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCHRCheer$1.17-31.0%$1.56$1.00▼$3.45$13.61M1.03100,061 shs596,457 shsFCFranklin Covey$18.87-0.9%$21.36$18.40▼$44.16$238.30M0.91128,688 shs79,181 shsNEONeoGenomics$5.80+0.7%$6.82$4.72▼$19.11$749.24M1.542.98 million shs1.84 million shsPAYPaymentus$33.99+0.8%$32.00$19.53▼$40.43$4.24B1.54773,237 shs944,555 shsAnalysts Agree—These Gold Picks Outshine the RestUnlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCHRCheer0.00%-36.41%-20.95%-21.21%-56.02%FCFranklin Covey0.00%+1.24%-9.58%-10.65%-50.78%NEONeoGenomics0.00%+12.40%-22.56%-27.95%-63.41%PAYPaymentus0.00%+20.15%+16.13%-7.89%+80.51%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationCHRCheer0.8152 of 5 stars0.05.00.00.00.01.70.6FCFranklin Covey3.8882 of 5 stars3.52.00.00.02.82.53.1NEONeoGenomics4.2744 of 5 stars4.25.00.00.03.03.31.3PAYPaymentus2.1303 of 5 stars1.34.00.00.02.64.21.3Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceCHRCheer 0.00N/AN/AN/AFCFranklin Covey 3.00Buy$31.0064.27% UpsideNEONeoGenomics 2.33Hold$12.75119.83% UpsidePAYPaymentus 2.50Moderate Buy$37.008.86% UpsideCurrent Analyst Ratings BreakdownLatest PAY, CHR, NEO, and FC Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails8/5/2025PAYPaymentusRaymond James FinancialSubscribe to MarketBeat All Access for the recommendation accuracy ratingSet Price TargetOutperform ➝ Outperform$38.008/4/2025NEONeoGenomicsPiper SandlerSubscribe to MarketBeat All Access for the recommendation accuracy ratingSet Price TargetOverweight ➝ Overweight$12.00 ➝ $11.007/30/2025NEONeoGenomicsMorgan StanleySubscribe to MarketBeat All Access for the recommendation accuracy ratingSet Price TargetEqual Weight ➝ Equal Weight$10.00 ➝ $8.007/30/2025NEONeoGenomicsBTIG ResearchSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Neutral7/29/2025NEONeoGenomicsNeedham & Company LLCSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetBuy ➝ Buy$8.50 ➝ $8.007/29/2025NEONeoGenomicsWilliam BlairSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingOutperform ➝ Market Perform7/22/2025PAYPaymentusWolfe ResearchSubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradePeer Perform ➝ Outperform7/7/2025FCFranklin CoveyRoth CapitalSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetBuy ➝ Buy$30.00 ➝ $27.007/3/2025FCFranklin CoveyBarrington ResearchSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingOutperform ➝ Outperform$35.006/4/2025PAYPaymentusRobert W. BairdSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetOutperform ➝ Outperform$36.00 ➝ $40.005/15/2025NEONeoGenomicsGuggenheimSubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageNeutral(Data available from 8/10/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookCHRCheer$147.20M0.09$2.93 per share0.40$29.66 per share0.04FCFranklin Covey$287.23M0.83$2.71 per share6.96$6.35 per share2.97NEONeoGenomics$660.57M1.13$0.44 per share13.22$7.03 per share0.83PAYPaymentus$871.74M4.88$0.74 per share45.77$3.89 per share8.74Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateCHRCheer$25.97MN/A0.00∞N/AN/AN/AN/AN/AFCFranklin Covey$23.40M$0.7923.8913.981.523.81%19.08%6.12%N/ANEONeoGenomics-$78.73M-$0.81N/A64.44N/A-15.10%-2.72%-1.54%N/APAYPaymentus$44.17M$0.4379.0577.25N/A5.37%12.63%10.69%N/ALatest PAY, CHR, NEO, and FC EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails8/4/2025Q2 2025PAYPaymentus$0.14$0.15+$0.01$0.11$262.78 million$280.08 million7/2/2025Q3 2025FCFranklin Covey-$0.08$0.18+$0.26-$0.11$67.49 million$67.12 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthCHRCheerN/AN/AN/AN/AN/AFCFranklin CoveyN/AN/AN/AN/AN/ANEONeoGenomicsN/AN/AN/AN/AN/APAYPaymentusN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioCHRCheerN/A8.297.66FCFranklin Covey0.020.840.81NEONeoGenomics0.403.923.58PAYPaymentusN/A4.564.46Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipCHRCheer18.54%FCFranklin Covey69.88%NEONeoGenomics98.50%PAYPaymentus78.38%Insider OwnershipCompanyInsider OwnershipCHRCheer41.70%FCFranklin Covey15.50%NEONeoGenomics2.40%PAYPaymentus87.76%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableCHRCheer12711.64 million6.78 millionN/AFCFranklin Covey1,08412.64 million10.68 millionOptionableNEONeoGenomics2,200129.18 million126.08 millionOptionablePAYPaymentus1,307125.13 million15.32 millionOptionablePAY, CHR, NEO, and FC HeadlinesRecent News About These CompaniesWedbush Issues Positive Forecast for Paymentus EarningsAugust 10 at 2:51 AM | americanbankingnews.comWhat is Wedbush's Forecast for Paymentus Q4 Earnings?August 9 at 10:26 AM | marketbeat.comPaymentus Holdings Stock (NYSE:PAY), Insider Trading ActivityAugust 8 at 8:23 AM | benzinga.comCenterBook Partners LP Raises Stock Holdings in Paymentus Holdings, Inc. (NYSE:PAY)August 8 at 7:05 AM | marketbeat.comPaymentus Holdings Reaches 80-Plus Relative Strength Rating BenchmarkAugust 7 at 4:51 AM | msn.comPaymentus Holdings Second Quarter 2025 Earnings: Beats ExpectationsAugust 7 at 4:51 AM | finance.yahoo.comPaymentus (NYSE:PAY) Shares Up 12.2% - What's Next?August 6, 2025 | marketbeat.comPaymentus Holdings: Strong Growth and Raised GuidanceAugust 5, 2025 | tipranks.comPaymentus (NYSE:PAY) Issues Quarterly Earnings ResultsAugust 5, 2025 | marketbeat.comPaymentus price target raised to $38 from $37 at Raymond JamesAugust 5, 2025 | msn.comPaymentus to Participate in Upcoming Investor Conferences in AugustAugust 5, 2025 | businesswire.comPaymentus shares surge as Q2 results and guidance top expectationsAugust 5, 2025 | investing.comPaymentus outlines raised 2025 revenue guidance to up to $1.132B while signaling confidence in multibillion-dollar growth trajectoryAugust 5, 2025 | msn.comPaymentus Holdings Reports Strong Q2 2025 ResultsAugust 4, 2025 | tipranks.comPaymentus Holdings, Inc. (PAY) Q2 2025 Earnings Call TranscriptAugust 4, 2025 | seekingalpha.comPaymentus Holdings, Inc. 2025 Q2 - Results - Earnings Call PresentationAugust 4, 2025 | seekingalpha.comPaymentus (PAY) Q2 Earnings and Revenues Surpass EstimatesAugust 4, 2025 | zacks.comPaymentus Holdings, Inc. (PAY): A Bull Case TheoryAugust 4, 2025 | insidermonkey.comPaymentus Reports Second Quarter 2025 Financial ResultsAugust 4, 2025 | businesswire.comFinancial Review: Paymentus (NYSE:PAY) versus Global Blue Group (NYSE:GB)August 4, 2025 | americanbankingnews.comPaymentus Holdings, Inc. (NYSE:PAY) Shares Bought by Universal Beteiligungs und Servicegesellschaft mbHJuly 29, 2025 | marketbeat.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeTop HeadlinesView All HeadlinesMeta's Q2 Earnings: Key Areas Investors Must Pay Attention ToBy Leo Miller | July 28, 2025View Meta's Q2 Earnings: Key Areas Investors Must Pay Attention ToBuild Stability and Income With 3 Overlooked Dividend LeadersBy Nathan Reiff | July 21, 2025View Build Stability and Income With 3 Overlooked Dividend Leaders3 High-Yield Bargains to Watch in 2025’s Second HalfBy Thomas Hughes | July 17, 2025View 3 High-Yield Bargains to Watch in 2025’s Second HalfQ2 Could Be the Catalyst PayPal Investors Have Been Waiting ForBy Sam Quirke | July 21, 2025View Q2 Could Be the Catalyst PayPal Investors Have Been Waiting For3 Stocks Every Value Investor Should Watch Out for Right NowBy Gabriel Osorio-Mazilli | August 4, 2025View 3 Stocks Every Value Investor Should Watch Out for Right NowPAY, CHR, NEO, and FC Company DescriptionsCheer NASDAQ:CHR$1.17 -0.53 (-30.97%) Closing price 08/8/2025 04:00 PM EasternExtended Trading$1.15 -0.02 (-1.79%) As of 08/8/2025 07:50 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Cheer Holding, Inc., through its subsidiaries, provides advertisement and content production services in the People's Republic of China. It operates through Cheers APP Internet Business and Traditional Media Businesses segments. The company also engages in mobile and online advertising, and media and entertainment businesses. In addition, it operates CHEERS app, an integrated e-commerce service with professionally produced content; CHEERS Video app, a media platform that engages users with content; and CHEERS e-Mall, an e-Mall app that offers products to the users through third party merchants through live streaming, online short videos, and online games. The company also provides CHEERS Telepathy, an artificial intelligence content creation platform; CHEERS Open Data, a platform that provides industry solutions; CheerCar, an interactive entertainment app; CheerReal, a digital collection NFT app; and production, such as short videos, online variety shows, online drama, live stream, and Cheers series. In addition, it is developing CheerChat App, a social app; and CHEERS Metaverse, a platform to provide immersive digital experiences. The company was formerly known as Glory Star New Media Group Holdings Limited and changed its name to Cheer Holding, Inc. in November 2023. Cheer Holding, Inc. was founded in 2016 and is headquartered in Beijing, the People's Republic of China.Franklin Covey NYSE:FC$18.87 -0.18 (-0.94%) Closing price 08/8/2025 03:59 PM EasternExtended Trading$18.84 -0.03 (-0.16%) As of 08/8/2025 05:46 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Franklin Covey Co. provides training and consulting services in the areas of execution, sales performance, productivity, customer loyalty, and educational improvement for organizations and individuals worldwide. The company operates through Direct Offices, International Licensees, and Education Practice segments. It also provides a suite of individual-effectiveness and leadership-development training and products. In addition, the company operates Strive platform, a learning deployment platform; Impact platform that helps automate implementation of learning initiatives; All Access Pass, a subscription platform that enables improved deployment of content, services, technology, and metrics to deliver behavioral impact at scale; and Leader in Me, which provides access to digital versions of student leadership guides, leadership lessons, illustrated leadership stories, and other resources. Franklin Covey Co. was incorporated in 1983 and is headquartered in Salt Lake City, Utah.NeoGenomics NASDAQ:NEO$5.80 +0.04 (+0.69%) Closing price 08/8/2025 04:00 PM EasternExtended Trading$5.74 -0.06 (-1.03%) As of 08/8/2025 05:06 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. It operates through Clinical Services and Advanced Diagnostics segments. The company offers testing services to hospitals, academic centers, pathologists, oncologists, clinicians, pharmaceutical companies, and clinical laboratories. It also provides cytogenetics testing services to study normal and abnormal chromosomes and their relationship to diseases; fluorescence in-situ hybridization testing services that focus on detecting and locating the presence or absence of specific DNA sequences and genes on chromosomes; flow cytometry testing services to measure the characteristics of cell populations; and immunohistochemistry and digital imaging testing services to localize cellular proteins in tissue section, as well as to allow clients to visualize scanned slides, and perform quantitative analysis for various stains. In addition, the company also provides molecular testing services, which focus on the analysis of DNA and/or RNA, and the structure and function of genes at the molecular level; morphologic analysis, which is the process of analyzing cells under the microscope by a pathologist for the purpose of diagnosis; and testing services in support of its pharmaceutical clients' oncology programs covering discovery and commercialization. NeoGenomics, Inc. was founded in 2001 and is headquartered in Fort Myers, Florida.Paymentus NYSE:PAY$33.99 +0.28 (+0.83%) Closing price 08/8/2025 03:59 PM EasternExtended Trading$33.18 -0.81 (-2.37%) As of 08/8/2025 08:00 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Paymentus Holdings, Inc. provides cloud-based bill payment technology and solutions in the United States and internationally. The company offers electronic bill presentment and payment services, enterprise customer communication, and self-service revenue management to billers through a software-as-a-service technology platform. Its platform's payment processing includes credit cards, debit cards, eChecks, and digital wallets. It serves utility, financial service, government, insurance, telecommunication, real estate management, education, consumer finance, healthcare, and small business industries. The company was founded in 2004 and is headquartered in Charlotte, North Carolina. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas MarketBeat Week in Review – 08/04 - 08/08 Rocket Lab Reports Q2 Results: Is the Bull Thesis Still Intact? Airbnb Beats Earnings, But the Growth Story Is Losing Altitude Dutch Bros Just Flipped the Script With a Massive Earnings Beat Amazon Takes an Equity Stake in IonQ—Any Upside Potential? D-Wave Delivers Growth Shock—Investors Eye Quantum Future Is Eli Lilly’s 14% Post-Earnings Slide a Buy-the-Dip Opportunity? Constellation Energy’s Earnings Beat Signals a New Era Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
